Literature DB >> 7427924

The effect of nerve growth factor on undifferentiated glioma cells.

S A Vinores, A Koestner.   

Abstract

Nerve growth factor (NGF) treatment of rats bearing implanted cells of an anaplastic glioma clone (F-98) led to a decreased tumor growth rate and increased survival time. Similar, but less pronounced, effects were observed if the cells were pretreated with NGF for 24 h before implantation. NGF also reduced the in vitro growth rate of F-98 and contributed to cellular maturation. Several well differentiated cell lines and clones were not visibly affected by NGF using the above parameters. We concluded that NGF has little or no effect on differentiated glioma cells, but significantly affects undifferentiated glioma cells by retarding their growth and inducing maturation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7427924     DOI: 10.1016/0304-3835(80)90047-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

Review 1.  From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D + all-trans retinoic acid + Temozolomide combination in treatment of GBM.

Authors:  Ilhan Elmaci; Aysel Ozpinar; Alp Ozpinar; Jennifer L Perez; Meric A Altinoz
Journal:  Metab Brain Dis       Date:  2019-04-01       Impact factor: 3.584

2.  The reverse transforming effects of nerve growth factor on five human neurogenic tumor cell lines: in vitro results.

Authors:  M J Yaeger; A Koestner; K Marushige; Y Marushige
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Mitogenesis in glioblastoma multiforme cell lines: a role for NGF and its TrkA receptors.

Authors:  H S Singer; B Hansen; D Martinie; C L Karp
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 4.  Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas.

Authors:  R F Barth
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

Review 5.  Invasiveness of primary brain tumors.

Authors:  O D Laerum; R Bjerkvig; S K Steinsvåg; L de Ridder
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  The effect of nerve growth factor and antibodies to nerve growth factor on ethylnitrosourea carcinogenesis in mice.

Authors:  S A Vinores; J R Perez-Polo
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

7.  The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results.

Authors:  M J Yaeger; A Koestner; K Marushige; Y Marushige
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 8.  Nerve growth factor: role in growth, differentiation and controlling cancer cell development.

Authors:  Luigi Aloe; Maria Luisa Rocco; Bijorn Omar Balzamino; Alessandra Micera
Journal:  J Exp Clin Cancer Res       Date:  2016-07-21

Review 9.  Regulation of the differentiation of PC12 pheochromocytoma cells.

Authors:  K Fujita; P Lazarovici; G Guroff
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.